Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1991 Sep;46(9):671–675. doi: 10.1136/thx.46.9.671

Quality of life measurement for patients undergoing treatment for lung cancer.

R J Fergusson 1, A Cull 1
PMCID: PMC463371  PMID: 1948799

Full text

PDF
671

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson N. K., Bullinger M., Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res. 1988;111:231–249. doi: 10.1007/978-3-642-83419-6_27. [DOI] [PubMed] [Google Scholar]
  2. Aaronson N. K. Methodologic issues in assessing the quality of life of cancer patients. Cancer. 1991 Feb 1;67(3 Suppl):844–850. doi: 10.1002/1097-0142(19910201)67:3+<844::aid-cncr2820671416>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  3. Aaronson N. K., Meyerowitz B. E., Bard M., Bloom J. R., Fawzy F. I., Feldstein M., Fink D., Holland J. C., Johnson J. E., Lowman J. T. Quality of life research in oncology. Past achievements and future priorities. Cancer. 1991 Feb 1;67(3 Suppl):839–843. doi: 10.1002/1097-0142(19910201)67:3+<839::aid-cncr2820671415>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  4. Allan S. G., Gregor A., Cornbleet M. A., Leonard R. C., Smyth J. F., Grant I. W., Crompton G. K. Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol. 1984;13(2):106–108. doi: 10.1007/BF00257124. [DOI] [PubMed] [Google Scholar]
  5. Bakker W., Nijhuis-Heddes J. M., van Oosterom A. T., Noordijk E. M., Hermans J., Dijkman J. H. Combined modality treatment of short duration in small cell lung cancer. Eur J Cancer Clin Oncol. 1984 Aug;20(8):1033–1037. doi: 10.1016/0277-5379(84)90105-6. [DOI] [PubMed] [Google Scholar]
  6. Bakker W., van Oosterom A. T., Aaronson N. K., van Breukelen F. J., Bins M. C., Hermans J. Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life. Eur J Cancer Clin Oncol. 1986 Aug;22(8):963–970. doi: 10.1016/0277-5379(86)90063-5. [DOI] [PubMed] [Google Scholar]
  7. Bergner M., Bobbitt R. A., Carter W. B., Gilson B. S. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981 Aug;19(8):787–805. doi: 10.1097/00005650-198108000-00001. [DOI] [PubMed] [Google Scholar]
  8. Bernhard J., Ganz P. A. Psychosocial issues in lung cancer patients (Part 1). Chest. 1991 Jan;99(1):216–223. doi: 10.1378/chest.99.1.216. [DOI] [PubMed] [Google Scholar]
  9. Bernhard J., Ganz P. A. Psychosocial issues in lung cancer patients (Part 2). Chest. 1991 Feb;99(2):480–485. doi: 10.1378/chest.99.2.480. [DOI] [PubMed] [Google Scholar]
  10. Carlens E., Dahlström G., Nõu E. Comparative measurements of quality of survival of lung cancer patients after diagnosis. Scand J Respir Dis. 1970;51(4):268–275. [PubMed] [Google Scholar]
  11. Cella D. F., Orofiamma B., Holland J. C., Silberfarb P. M., Tross S., Feldstein M., Perry M., Maurer L. H., Comis R., Orav E. J. The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer. Cancer. 1987 Oct 1;60(7):1661–1667. doi: 10.1002/1097-0142(19871001)60:7<1661::aid-cncr2820600740>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  12. Coates A., Dillenbeck C. F., McNeil D. R., Kaye S. B., Sims K., Fox R. M., Woods R. L., Milton G. W., Solomon J., Tattersall M. H. On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol. 1983 Nov;19(11):1633–1637. doi: 10.1016/0277-5379(83)90096-2. [DOI] [PubMed] [Google Scholar]
  13. Fallowfield L. J., Baum M., Maguire G. P. Do psychological studies upset patients? J R Soc Med. 1987 Jan;80(1):59–59. doi: 10.1177/014107688708000124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fernandez C., Rosell R., Abad-Esteve A., Monras P., Moreno I., Serichol M., Roviralta M. Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol. 1989;28(1):29–33. doi: 10.3109/02841868909111177. [DOI] [PubMed] [Google Scholar]
  15. Ganz P. A., Haskell C. M., Figlin R. A., La Soto N., Siau J. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer. Cancer. 1988 Feb 15;61(4):849–856. doi: 10.1002/1097-0142(19880215)61:4<849::aid-cncr2820610435>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  16. Geddes D. M., Dones L., Hill E., Law K., Harper P. G., Spiro S. G., Tobias J. S., Souhami R. L. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer. 1990 Apr;26(4):484–492. doi: 10.1016/0277-5379(90)90022-l. [DOI] [PubMed] [Google Scholar]
  17. Greenberg E. R., Chute C. G., Stukel T., Baron J. A., Freeman D. H., Yates J., Korson R. Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med. 1988 Mar 10;318(10):612–617. doi: 10.1056/NEJM198803103181006. [DOI] [PubMed] [Google Scholar]
  18. Harvey V. J., Slevin M. L., Cheek S. P., Barnett M. J., Gregory W., Thompson J. P., Wrigley P. F. A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1615–1619. doi: 10.1016/0277-5379(87)90439-1. [DOI] [PubMed] [Google Scholar]
  19. Hughes J. E. Depressive illness and lung cancer. II. Follow-up of inoperable patients. Eur J Surg Oncol. 1985 Mar;11(1):21–24. [PubMed] [Google Scholar]
  20. Hunt S. M., McEwen J. The development of a subjective health indicator. Sociol Health Illn. 1980 Nov;2(3):231–246. doi: 10.1111/1467-9566.ep11340686. [DOI] [PubMed] [Google Scholar]
  21. Hutchinson T. A., Boyd N. F., Feinstein A. R., Gonda A., Hollomby D., Rowat B. Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis. 1979;32(9-10):661–666. doi: 10.1016/0021-9681(79)90096-1. [DOI] [PubMed] [Google Scholar]
  22. Jennett B., Buxton M. When is treatment for cancer economically justified? Discussion paper. J R Soc Med. 1990 Jan;83(1):25–28. doi: 10.1177/014107689008300112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kaasa S., Mastekaasa A., Naess S. Quality of life of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire. Acta Oncol. 1988;27(4):335–342. doi: 10.3109/02841868809093551. [DOI] [PubMed] [Google Scholar]
  24. Kaasa S., Mastekaasa A. Psychosocial well-being of patients with inoperable non-small cell lung cancer. The importance of treatment- and disease-related factors. Acta Oncol. 1988;27(6B):829–835. doi: 10.3109/02841868809094368. [DOI] [PubMed] [Google Scholar]
  25. Maguire P., Selby P. Assessing quality of life in cancer patients. Br J Cancer. 1989 Sep;60(3):437–440. doi: 10.1038/bjc.1989.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Minet P., Bartsch P., Chevalier P., Raets D., Gras A., Dejardin-Closon M. T., Lennes G. Quality of life of inoperable non-small cell lung carcinoma. A randomized phase II clinical study comparing radiotherapy alone and combined radio-chemotherapy. Radiother Oncol. 1987 Mar;8(3):217–230. doi: 10.1016/s0167-8140(87)80245-1. [DOI] [PubMed] [Google Scholar]
  27. Moinpour C. M., Feigl P., Metch B., Hayden K. A., Meyskens F. L., Jr, Crowley J. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst. 1989 Apr 5;81(7):485–495. doi: 10.1093/jnci/81.7.485. [DOI] [PubMed] [Google Scholar]
  28. Mor V., Laliberte L., Morris J. N., Wiemann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer. 1984 May 1;53(9):2002–2007. doi: 10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  29. Morrow G. R., Chiarello R. J., Derogatis L. R. A new scale for assessing patients' psychosocial adjustment to medical illness. Psychol Med. 1978 Nov;8(4):605–610. doi: 10.1017/s003329170001881x. [DOI] [PubMed] [Google Scholar]
  30. Nõu E., Aberg T. Quality of survival in patients with surgically treated bronchial carcinoma. Thorax. 1980 Apr;35(4):255–263. doi: 10.1136/thx.35.4.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Nõu E., Eklund G. Bronchial carcinoma. IV. A methodological evaluation of the vitagram index for measurement of quality of survival. Scand J Respir Dis Suppl. 1979;104:131–171. [PubMed] [Google Scholar]
  32. Priestman T. J., Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet. 1976 Apr 24;1(7965):899–900. doi: 10.1016/s0140-6736(76)92112-7. [DOI] [PubMed] [Google Scholar]
  33. Schag C. C., Heinrich R. L., Ganz P. A. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984 Mar;2(3):187–193. doi: 10.1200/JCO.1984.2.3.187. [DOI] [PubMed] [Google Scholar]
  34. Schipper H., Clinch J., McMurray A., Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol. 1984 May;2(5):472–483. doi: 10.1200/JCO.1984.2.5.472. [DOI] [PubMed] [Google Scholar]
  35. Selby P. J., Chapman J. A., Etazadi-Amoli J., Dalley D., Boyd N. F. The development of a method for assessing the quality of life of cancer patients. Br J Cancer. 1984 Jul;50(1):13–22. doi: 10.1038/bjc.1984.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Slevin M. L., Plant H., Lynch D., Drinkwater J., Gregory W. M. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988 Jan;57(1):109–112. doi: 10.1038/bjc.1988.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Spitzer W. O., Dobson A. J., Hall J., Chesterman E., Levi J., Shepherd R., Battista R. N., Catchlove B. R. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis. 1981;34(12):585–597. doi: 10.1016/0021-9681(81)90058-8. [DOI] [PubMed] [Google Scholar]
  38. Splinter T. A. Chemotherapy in advanced non-small cell lung cancer. Eur J Cancer. 1990;26(10):1093–1099. doi: 10.1016/0277-5379(90)90059-3. [DOI] [PubMed] [Google Scholar]
  39. Sugarbaker P. H., Barofsky I., Rosenberg S. A., Gianola F. J. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery. 1982 Jan;91(1):17–23. [PubMed] [Google Scholar]
  40. Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party. Respir Med. 1989 Jan;83(1):51–58. doi: 10.1016/s0954-6111(89)80060-5. [DOI] [PubMed] [Google Scholar]
  41. Yates J. W., Chalmer B., McKegney F. P. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980 Apr 15;45(8):2220–2224. doi: 10.1002/1097-0142(19800415)45:8<2220::aid-cncr2820450835>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  42. de Haes J. C., van Knippenberg F. C., Neijt J. P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990 Dec;62(6):1034–1038. doi: 10.1038/bjc.1990.434. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES